Source: International Congress 2019 – Clinical approach to asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Halner (Oxford, United Kingdom), S. Beer (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom). Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease. 2726

Member's Comments

No comment yet.

Related content which might interest you: Patients with COPD prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils? Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Predicting treatment outcomes following an exacerbation of airways disease Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease? Source: Annual Congress 2003 - COPD: risk factors and course of disease Year: 2003 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Patient perspectives on systemic corticosteroids in asthma Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Duration of systemic corticosteroids treatment in COPD exacerbations Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Is it effective to administer corticosteroids late for neonatal chronic lung disease? Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004 Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Characteristics of paediatric difficult asthma and systemic corticosteroid responsiveness Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001